Considering the beta particle tissue range (+/−2 mm) of radioligand therapy with 177Lu-PSMA, it could potentially still reach nearby tumour cells in well-perfused malignancies, even if PSMA is exclusively over-expressed in the endothelial cells of neo-vasculature, with resultant abscopal effect. This evidence concerns the gene FOLH1 and neoplasm.